24/7 Market News Snapshot 22 July, 2025 – Beyond Air, Inc. Common Stock (NASDAQ:XAIR)

July 22, 2025

DENVER, Colo., 22 July, 2025 (www.247marketnews.com) – (NASDAQ:XAIR) are discussed in this article.
Beyond Air, Inc. is witnessing a positive momentum in the stock market, trading at $3.365 during pre-market hours with a notable gain of approximately 1.36% from the previous close of $3.320. This surge is accompanied by a significant trading volume of 1.79 million shares, reflecting strong investor interest and buying pressure. Analysts are encouraged to keep a close watch on key resistance levels and volume patterns, which could indicate potential breakout opportunities. Continuous upward movement may suggest further gains, while established support levels provide insights for risk management strategies in this dynamic trading environment.

In tandem with this bullish market activity, Beyond Air has announced a strategic partnership with Premier, Inc., aimed at enhancing the accessibility of its groundbreaking LungFit PH system. Effective July 15, this national group purchasing agreement allows healthcare providers within the Premier network to benefit from special pricing and terms for the LungFit PH system and its integrated disposable NO2 Smart Filters.

Steve Lisi, the Chairman and Chief Executive Officer of Beyond Air, expressed enthusiasm over the partnership, highlighting its significance in broadening patient access to the advanced, cylinder-free nitric oxide delivery system. This system not only presents a safer, more efficient treatment option but also utilizes patented Ionizer™ technology to generate unlimited, on-demand nitric oxide directly from ambient air.

The LungFit PH platform is specifically designed for the treatment of pulmonary hypertension in neonates, capable of delivering clinically relevant doses of nitric oxide while ensuring minimal byproduct generation. As Beyond Air moves forward with ongoing clinical trials and additional LungFit systems, this collaboration with Premier underscores the company’s commitment to advancing patient care through innovative therapeutic technologies and strategic alliances.

Related news for (XAIR)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.